Within trial comparison of survival time projections from short‐term follow‐up with long‐term follow‐up findings
Abstract Aims Data on long‐term treatment effects are scarce, despite the intent to use new therapies for many years and the need of patients, physicians and payers to have a better understanding of the lifetime benefits of treatments. The restricted mean or median survival time (RMST) calculated us...
Main Authors: | João Pedro Ferreira, Brian L. Claggett, Kieran F. Docherty, Pardeep S. Jhund, Faiez Zannad, Scott D. Solomon, John J.V. McMurray |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13731 |
Similar Items
-
Critically ill patient mortality by age: long-term follow-up (CIMbA-LT)
by: João Gonçalves-Pereira, et al.
Published: (2023-02-01) -
Extended long-term follow-up of metastatic melanoma patients treated with immunotherapy: late relapses and second primary melanomas
by: David R. Minor, et al.
Published: (2023-12-01) -
Long-term follow-up in surgical newborns: A single-institution experience
by: Hajime Takayasu, et al.
Published: (2020-12-01) -
Long-Term Care and Follow-Up in Laryngeal Cancer Patients: A Multicenter Retrospective Analysis
by: Blažen Marijić, et al.
Published: (2023-05-01) -
Utility of Regular Radiological Follow-up on Early Detection of Contralateral Malignancy and Long-term Outcomes in Metachronous Bilateral Breast Cancer Patients
by: Hyo Sun Kim, et al.
Published: (2017-06-01)